Accredited CME Conference - New Cardiovascular Horizons (NCVH) is a leading Peripheral Intervention Conference focusing on Peripheral Artery Disease (PAD) with a special emphasis on Critical Limb Ischemia (CLI).
Information for patients and physicians about the risk factors, diagnosis and treatment of Periperal Arterial Disease (PAD) and Critical Limb Ischemia (CLI)
Lifecells is currently conducting clinical trials using a stem cell product, to treat CLI, or Critical Limb Ischemia; the most severe form of peripheral arterial disease.
Lifecells is currently conducting clinical trials using a stem cell product, to treat CLI, or Critical Limb Ischemia; the most severe form of peripheral arterial disease.
EKOS ultrasound accelerated infusion catheters deliver thrombolytic drugs to targeted locations in the peripheral vasculature for rapid dissolution of blood clots. Other applications include delivery of physician-prescribed fluids to the pulmonary arteri
Kasiak Holding AG Biotech Company does regenerative medicine and uses adipose tissue to extract stem cells from for autologous use for treatment of diabetic foot ulcer with a goal is to avoid the otherwise inescapable (partial) amputation of lower limbs i
Kasiak Holding AG Biotech Company does regenerative medicine and uses adipose tissue to extract stem cells from for autologous use for treatment of diabetic foot ulcer with a goal is to avoid the otherwise inescapable (partial) amputation of lower limbs i
Kasiak Holding AG Biotech Company does regenerative medicine and uses adipose tissue to extract stem cells from for autologous use for treatment of diabetic foot ulcer with a goal is to avoid the otherwise inescapable (partial) amputation of lower limbs i
Accredited CME Conference - New Cardiovascular Horizons (NCVH) is a leading Peripheral Intervention Conference focusing on Peripheral Artery Disease (PAD) with a special emphasis on Critical Limb Ischemia (CLI).
Information for patients and physicians about the risk factors, diagnosis and treatment of Periperal Arterial Disease (PAD) and Critical Limb Ischemia (CLI)
Lifecells is currently conducting clinical trials using a stem cell product, to treat CLI, or Critical Limb Ischemia; the most severe form of peripheral arterial disease.
Lifecells is currently conducting clinical trials using a stem cell product, to treat CLI, or Critical Limb Ischemia; the most severe form of peripheral arterial disease.
Paradigm Safety Integration is a service company, which monitors situations where timely critical data prevents life and limb threatening events from escalating to a reportable incident.
Paradigm Safety Integration is a service company, which monitors situations where timely critical data prevents life and limb threatening events from escalating to a reportable incident.
Paradigm Safety Integration is a service company, which monitors situations where timely critical data prevents life and limb threatening events from escalating to a reportable incident.
Paradigm Safety Integration is a service company, which monitors situations where timely critical data prevents life and limb threatening events from escalating to a reportable incident.
Paradigm Safety Integration is a service company, which monitors situations where timely critical data prevents life and limb threatening events from escalating to a reportable incident.
EKOS ultrasound accelerated infusion catheters deliver thrombolytic drugs to targeted locations in the peripheral vasculature for rapid dissolution of blood clots. Other applications include delivery of physician-prescribed fluids to the pulmonary arteri
Kasiak Holding AG Biotech Company does regenerative medicine and uses adipose tissue to extract stem cells from for autologous use for treatment of diabetic foot ulcer with a goal is to avoid the otherwise inescapable (partial) amputation of lower limbs i